Redistribution of the CDK inhibitor p27 between different cyclin·CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation

Molecular Biology of the Cell

Volumn 6, Issue 9, 1995, Pages 1197-1213

  Poon, Randy Y C ^a   Toyoshima, Hideo ^a   Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; GROWTH FACTOR; MEVINOLIN; PROTEIN KINASE INHIBITOR; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME INHIBITOR COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; ULTRAVIOLET IRRADIATION;

ANIMALIA;

EID: 0029145975     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.6.9.1197     Document Type: Article

References (54)

1. ink4. Mol. Cell. Biol. 15, 2682-2688.
2. Coleman, T.R., and Dunphy, W.G. (1994). Cdc2 regulatory factors. Curr. Opin. Cell Biol. 6, 877-882.
3. Connell-Crowley, L., Solomon, M.J., Wei, N., and Harper, J.W. (1993). Phosphorylation independent activation of human cyclindependent kinase 2 by cyclin A in vitro. Mol. Biol. Cell 4, 79-92.
4. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y., and Wang, X.-F. (1995). Transformating growth factor β induces the cyclindependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
5. Dulić, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J., and Reed, S.I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023.
6. El Deiry, W.S., et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174.
7. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
8. Elledge, S.J., and Harper, J.W. (1994). Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6, 847-852.
9. Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M. (1993). TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020.
10. Fisher, R.P., and Morgan, D.O. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
11. Gu, Y., Turck, C.W., and Morgan, D.O. (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.
12. Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X.Y., Okeefe, C.L., Matera, A.G., and Xiong, Y. (1994). Growth suppression by p18, a p16(INK4/MTS1)- and p14(INK4B/MTS2)-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
13. Halevy, O., Novitch, B.C., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021.
14. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
15. Harper, J.W., Adami, G.R., Wei, N., Keyomars, K., and Elledge, E.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
16. Harper, J.W., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
17. Heichman, K.A., and Roberts, J.M. (1994). Rules to replicate by. Cell 79, 557-562.
18. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E., and Reed, S.I. (1994). A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91, 5291-5295.
19. Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A., and Sherr, C.J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
20. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
21. Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
22. Keyomarsi, K., Sandoval, L., Band, V., and Pardee, A.B. (1991). Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51, 3602-3609.
23. King, R.W., Jackson, P.K., and Kirschner, M.W. (1994). Mitosis in transition. Cell 79, 563-571.
24. Ko, T.C., Sheng, H.M., Reisman, D., Thompson, E.A., and Beauchamp, R.D. (1995). Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10, 177-184.
25. Kobayashi, H., Golsteyn, R., Poon, R., Stewart, E., Gannon, J., Minshull, J., Smith, R., and Hunt, T. (1991). Cyclins and their partners during Xenopus oocyte maturation. Cold Spring Harbor Symp. Quant. Biol. 56, 437-447.
26. Kornbluth, S., Sebastian, B., Hunter, T., and Newport, J. (1994). Membrane localization of the kinase which phosphorylates p34cdc2 on threonine 14. Mol. Biol. Cell 5, 273-282.
27. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
28. Li, R., Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994a). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534-537.
29. Li, Y., Jenkins, C.W., Nichols, M.A., and Xiong, Y. (1994b). Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261-2268.
30. Mäkelä, T.P., Tassan, J.-P., Nigg, E.A., Frutiger, S., Hughes, G.J., and Weinberg, R.A. (1994). A cyclin associated with the CDK-activating kinase MO15. Nature 371, 254-257.
31. Matsuoka, M., Kato, J.Y., Fisher, R.P., Morgan, D.O., and Sherr, C.J. (1994). Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14, 7265-7275.
32. CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
33. Morgan, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
34. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression system. Exp. Cell Res. 211, 90-98.
35. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
36. Pagano, M., Theodoras, A.M., Tam, S.W., and Draetta, G.F. (1994). Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8, 1627-1639.
37. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027.
38. INK4/MTS1tumour suppressor gene product. EMBO J. 14, 503-511.
39. KiP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
40. KiP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
41. Poon, R.Y.C., and Hunt, T. (1994). Reversible immunoprecipitation using histidine- or glutathione-S-transferase-tagged staphylococcal protein A. Anal. Biochem. 218, 26-33.
42. cdc2. EMBO J. 12, 3123-3132.
43. MO15. J. Cell Sci. 107, 2789-2799.
44. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366, 704-707.
45. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
46. Skapek, S.X., Rhee, J., Spicer, D.B., and Lassar, A.B. (1995). Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267, 1022-1024.
47. Slingerland, J.M., Hengst, L., Pan, C-H., Alexander, D., Stampfer, M., and Reed, S.I. (1994). A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
48. MO15. EMBO J. 12, 3133-3142.
49. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78, 67-74.
50. Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
51. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993a). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
52. Xiong, Y., Zhang, H., and Beach, D. (1992). D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 72, 504-514.
53. Xiong, Y., Zhang, H., and Beach, D. (1993b). Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572-1583.
54. Zhang, H., Hannon, G.J., and Beach, D. (1994). p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758.